Beyond	IN
TGFb	NN
-	:
Novel	JJ
ways	NNS
to	TO
target	VB
airway	NN
and	CC
parenchymal	JJ
fibrosis	NN
.	.

Within	IN
the	DT
lungs	NNS
,	,
fibrosis	NN
can	MD
affect	VB
both	CC
the	DT
parenchyma	NN
and	CC
the	DT
airways	NNS
.	.

Fibrosis	NN
is	VBZ
a	DT
hallmark	NN
pathological	JJ
change	NN
in	IN
the	DT
parenchyma	NN
in	IN
patients	NNS
with	IN
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
,	,
whilst	IN
in	IN
asthma	NN
or	CC
chronic	JJ
obstructive	JJ
pulmonary	JJ
disease	NN
(	(
COPD	NN
)	)
fibrosis	NN
is	VBZ
a	DT
component	NN
of	IN
the	DT
remodelling	NN
of	IN
the	DT
airways	NNS
.	.

In	IN
the	DT
past	JJ
decade	NN
,	,
significant	JJ
advances	NNS
have	VBP
been	VBN
made	VBN
in	IN
understanding	VBG
the	DT
disease	NN
behaviour	NN
and	CC
pathogenesis	NN
of	IN
parenchymal	NN
and	CC
airway	NN
fibrosis	NN
and	CC
as	IN
a	DT
result	NN
a	DT
variety	NN
of	IN
novel	JJ
therapeutic	JJ
targets	NNS
for	IN
slowing	VBG
or	CC
preventing	VBG
progression	NN
of	IN
these	DT
fibrotic	JJ
changes	NNS
have	VBP
been	VBN
identified	VBN
.	.

This	DT
review	NN
highlights	VBZ
a	DT
number	NN
of	IN
these	DT
targets	NNS
and	CC
discusses	VBZ
the	DT
potential	NN
for	IN
treating	VBG
parenchymal	JJ
or	CC
airway	NN
fibrosis	NN
through	IN
these	DT
mediators/pathways	NNS
in	IN
the	DT
future	NN
.	.

